Recent News

• 05.20.2025 - RBC Capital Markets Global Healthcare Conference
• 05.13.2025 - BofA Securities Health Care Conference
• 05.07.2025 - Xencor Reports First Quarter 2025 Financial Results
• 04.29.2025 - Interim Results from First-in-Human Study of XmAb942 & TL1A Pipeline Update
• 04.29.2025 - Xencor Announces Positive Interim Results From First-in-Human Healthy Volunteer Study of XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, in Development for Treatment of Inflammatory Bowel Disease
• 04.21.2025 - Matt Phipps, Ph.D.
• 03.13.2025 - Todd Simpson

Recent Filings

• 05.07.2025 - 8-K Current report
• 05.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.07.2025 - EX-99.1 EX-99.1
• 05.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.02.2025 - 144 Report of proposed sale of securities
• 04.30.2025 - EX-99.1 EX-99.1
• 04.30.2025 - 8-K Current report
• 04.29.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.23.2025 - DEF 14A Other definitive proxy statements
• 04.23.2025 - ARS Annual Report to Security Holders